An update on semaglutide for CKD in the presence of T2D
Description
In this Product Explainer, Endocrinologist Prof Richard MacIsaac provides an update on the chronic kidney disease (CKD) indication for semaglutide, explains the PBS criteria and how healthcare professionals can initiate this GLP-1 RA.
NEXT LIVE Webcast
:
Days
:
Hours
:
Minutes
Seconds
A/Prof Debbie Rigby
Why Inhaler Device Design and Technique Matters
Dr Philip Tong
Facial Rashes Case Studies – Practical Guide to Assessment and Management
Dr Rupert Hinds
Abdominal Pain in Children – Practical Approach in GP
Prof Roger Chen
Practical Guide to Improving Control of T2D
Join us for the next free webcast for GPs and healthcare professionals
High quality lectures delivered by leading independent experts
